AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Myeloproliferative disorders
Authors: Bench, AJ Cross, NCP Huntly, BJP Nacheva, EP Green, AR
Citation: Aj. Bench et al., Myeloproliferative disorders, BEST P R C, 14(3), 2001, pp. 531-551
Cytogenetics of chronic myeloid leukaemia
Authors: Chase, A Huntly, BJP Cross, NCP
Citation: A. Chase et al., Cytogenetics of chronic myeloid leukaemia, BEST P R C, 14(3), 2001, pp. 553-571
Identification of four new translocations involving FGFRI in myeloid disorders
Authors: Sohal, J Chase, A Mould, S Corcoran, M Oscier, D Iqbal, S Parker, S Welborn, J Harris, RI Martinelli, G Montefusco, V Sinclair, P Wilkins, BS van den Berg, H Vanstraelen, D Goldman, JM Cross, NCP
Citation: J. Sohal et al., Identification of four new translocations involving FGFRI in myeloid disorders, GENE CHROM, 32(2), 2001, pp. 155-163
Mutations of the transcription factor AML1/CBFA2 are uncommon in blastic transformation of chronic myeloid leukaemia
Authors: Steer, EJ Goldman, JM Cross, NCP
Citation: Ej. Steer et al., Mutations of the transcription factor AML1/CBFA2 are uncommon in blastic transformation of chronic myeloid leukaemia, LEUKEMIA, 15(3), 2001, pp. 476-477
Roots of clinical resistance to STI-571 cancer therapy
Authors: Hochhaus, A Kreil, S Corbin, A La Rosee, P Lahaye, T Berger, U Cross, NCP Linkesch, W Druker, BJ Hehlmann, R
Citation: A. Hochhaus et al., Roots of clinical resistance to STI-571 cancer therapy, SCIENCE, 293(5538), 2001, pp. NIL_1-NIL_3
ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia
Authors: de la Fuente, J Merx, K Steer, EJ Muller, M Szydlo, RM Maywald, O Berger, U Hehlmann, R Goldman, JM Cross, NCP Melo, JV Hochhaus, A
Citation: J. De La Fuente et al., ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia, BLOOD, 98(9), 2001, pp. 2879-2880
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novochildhood acute myeloid leukemia
Authors: Jaju, RJ Fidler, C Haas, OA Strickson, AJ Watkins, F Clark, K Cross, NCP Cheng, JF Aplan, PD Kearney, L Boultwood, J Wainscoat, JS
Citation: Rj. Jaju et al., A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novochildhood acute myeloid leukemia, BLOOD, 98(4), 2001, pp. 1264-1267
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
Authors: Demiroglu, A Steer, EJ Heath, C Taylor, K Bentley, M Allen, SL Koduru, P Brody, JP Hawson, G Rodwell, R Doody, ML Carnicero, F Reiter, A Goldman, JM Melo, JV Cross, NCP
Citation: A. Demiroglu et al., The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins, BLOOD, 98(13), 2001, pp. 3778-3783
The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells
Authors: Lewis, JL Chinswangwatanakul, W Zheng, B Marley, SB Nguyen, DX Cross, NCP Banerji, L Glassford, J Thomas, NSB Goldman, JM Lam, EWF Gordon, MY
Citation: Jl. Lewis et al., The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells, BLOOD, 97(9), 2001, pp. 2604-2610
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia
Authors: Olavarria, E Kanfer, E Szydlo, R Kaeda, J Rezvani, K Cwynarski, K Pocock, C Dazzi, F Craddock, C Apperley, JF Cross, NCP Goldman, JM
Citation: E. Olavarria et al., Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 97(6), 2001, pp. 1560-1565
Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia
Authors: Chase, A Pickard, J Szydlo, R Coulthard, S Goldman, JM Cross, NCP
Citation: A. Chase et al., Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia, GENE CHROM, 27(3), 2000, pp. 278-284
Detection and quantification of residual disease in chronic myelogenous leukemia
Authors: Hochhaus, A Weisser, A La Rosee, P Emig, M Muller, MC Saussele, S Reiter, A Kuhn, C Berger, U Hehlmann, R Cross, NCP
Citation: A. Hochhaus et al., Detection and quantification of residual disease in chronic myelogenous leukemia, LEUKEMIA, 14(6), 2000, pp. 998-1005
Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: Comparison of quantitative polymerase chain reaction and immunocytochemical techniques
Authors: Smith, BM Slade, MJ English, J Graham, H Luchtenborg, M Sinnett, HD Cross, NCP Coombes, RC
Citation: Bm. Smith et al., Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: Comparison of quantitative polymerase chain reaction and immunocytochemical techniques, J CL ONCOL, 18(7), 2000, pp. 1432-1439
Cloning of ZNF237, a novel member of the MYM gene family that maps to human chromosome 13q11 -> q12
Authors: Sohal, J Reiter, A Goldman, JM Cross, NCP
Citation: J. Sohal et al., Cloning of ZNF237, a novel member of the MYM gene family that maps to human chromosome 13q11 -> q12, CYTOG C GEN, 89(1-2), 2000, pp. 24-28
Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)
Authors: Kulkarni, S Heath, C Parker, S Chase, A Iqbal, S Pocock, CF Kaeda, J Cwynarski, K Goldman, JM Cross, NCP
Citation: S. Kulkarni et al., Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21), CANCER RES, 60(13), 2000, pp. 3592-3598
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
Authors: Dazzi, F Szydlo, RM Cross, NCP Craddock, C Kaeda, J Kanfer, E Cwynarski, K Olavarria, E Yong, A Apperley, JF Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2612-2616
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
Authors: Dazzi, F Szydlo, RM Cross, NCP Craddock, C Kaeda, J Kanfer, E Cwynarski, K Olavarria, E Yong, A Apperley, JF Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2712-2716
Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia
Authors: Chase, A Parker, S Kaeda, J Sivalingam, R Cross, NCP Goldman, JM
Citation: A. Chase et al., Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia, BLOOD, 96(2), 2000, pp. 777-778
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission
Authors: Hochhaus, A Reiter, A Saussele, S Reichert, A Emig, M Kaeda, J Schultheis, B Berger, U Shepherd, PCA Allan, NC Hehlmann, R Goldman, JM Cross, NCP
Citation: A. Hochhaus et al., Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission, BLOOD, 95(1), 2000, pp. 62-66
Comparison of single-dose and escalating-dose regimens of donor lymphocyteinfusion for relapse after allografting for chronic myeloid leukemia
Authors: Dazzi, F Szydlo, RM Craddock, C Cross, NCP Kaeda, J Chase, A Olavarria, E van Rhee, F Kanfer, E Apperley, JF Goldman, JM
Citation: F. Dazzi et al., Comparison of single-dose and escalating-dose regimens of donor lymphocyteinfusion for relapse after allografting for chronic myeloid leukemia, BLOOD, 95(1), 2000, pp. 67-71
Cloning and characterization of RNF6, a novel RING finger gene mapping to 13q12
Authors: Macdonald, DHC Lahiri, D Sampath, A Chase, A Sohal, J Cross, NCP
Citation: Dhc. Macdonald et al., Cloning and characterization of RNF6, a novel RING finger gene mapping to 13q12, GENOMICS, 58(1), 1999, pp. 94-97
The genomic structure of ZNF198 and location of breakpoints in the t(8;13)myeloproliferative syndrome
Authors: Kulkarni, S Reiter, A Smedley, D Goldman, JM Cross, NCP
Citation: S. Kulkarni et al., The genomic structure of ZNF198 and location of breakpoints in the t(8;13)myeloproliferative syndrome, GENOMICS, 55(1), 1999, pp. 118-121
Accurate and rapid analysis of residual disease in patients with CML usingspecific fluorescent hybridization probes for real time quantitative RT-PCR
Authors: Emig, M Saussele, S Wittor, H Weisser, A Reiter, A Willer, A Berger, U Hehlmann, R Cross, NCP Hochhaus, A
Citation: M. Emig et al., Accurate and rapid analysis of residual disease in patients with CML usingspecific fluorescent hybridization probes for real time quantitative RT-PCR, LEUKEMIA, 13(11), 1999, pp. 1825-1832
Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer
Authors: Slade, MJ Smith, BM Sinnett, HD Cross, NCP Coombes, RC
Citation: Mj. Slade et al., Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer, J CL ONCOL, 17(3), 1999, pp. 870-879
The 8p11 myeloproliferative syndrome
Authors: Reiter, A Hehlmann, R Goldman, JM Cross, NCP
Citation: A. Reiter et al., The 8p11 myeloproliferative syndrome, MED KLIN, 94(4), 1999, pp. 207-210
Risultati: 1-25 | 26-34